Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to 0.12%.

  • Cellebrite DI's Return on Capital Employed fell 5.00% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of 0.18% for FY2024, which is 2.00% up from last year.
  • As of Q3 2025, Cellebrite DI's Return on Capital Employed stood at 0.12%, which was down 11.84% from 0.14% recorded in Q2 2025.
  • Cellebrite DI's 5-year Return on Capital Employed high stood at 0.18% for Q3 2024, and its period low was 0.04% during Q2 2023.
  • Over the past 3 years, Cellebrite DI's median Return on Capital Employed value was 0.14% (recorded in 2025), while the average stood at 0.13%.
  • In the last 5 years, Cellebrite DI's Return on Capital Employed declined by 6bps in 2023 and then climbed by 13bps in 2024.
  • Cellebrite DI's Return on Capital Employed (Quarterly) stood at 0.14% in 2021, then dropped by 3bps to 0.11% in 2022, then rose by 2bps to 0.13% in 2023, then grew by 2bps to 0.16% in 2024, then declined by 5bps to 0.12% in 2025.
  • Its last three reported values are 0.12% in Q3 2025, 0.14% for Q2 2025, and 0.15% during Q1 2025.